BSE filing, NSE: SPANDIAQ. Summary written from the filing by ALFA Finder's alert engine.
Span Divergent Ltd: key numbers
- Share price
- ₹28.08
- Market cap
- ₹20.40 Cr
- Revenue (annual)
- ₹17.22 Cr
- Net profit (annual)
- ₹-2.50 Cr
- P/E (TTM)
- -6.5×Sector 37.9×
- Promoter holding
- 48.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Span Divergent Ltd
All →Span Divergent Legal & Regulatory
Span Divergent received a partly favourable CIT(Appeals) order for AY 2018-19 deleting a ₹1,57,500 Section 69C addition. The order is a tax matter with no business impact stated.
- Value
- ₹0.02 Cr
Span Divergent Legal & Regulatory
Span Divergent received a CIT(Appeals) order dated November 4, 2026, partly allowing its appeal for AY 2017-18. The ₹1,50,000 addition under Section 69C was deleted, and the company says there is no impact on operations.
- Value
- ₹0.01 Cr
Span Divergent Legal & Regulatory
Span Divergent's tax appeal was partly allowed, quashing the AY 2016-17 assessment order. Disallowances of ₹64.15 lakh were quashed; the tax demand impact will follow.
- Value
- ₹0.64 Cr
Span Divergent Merger & Restructuring Worth ₹5 Cr
Span Divergent's board approved selling its Mumbai immovable property to Glorious Sales LLP, an unrelated buyer, for up to Rs.5 Crore. Completion is expected by March 31, 2027.
- Value
- ₹5.00 Cr
- Execution
- Agreement to be executed on or before March 31, 2027; sale expected to complete on or before March 31, 2027
Span Divergent Debt & Borrowing: ₹0.68 Cr
Span Divergent increased its HDFC Bank corporate guarantee for subsidiary Dryfruit Factory LLP by ₹0.68 Crore. Total guarantee now ₹5.68 Crore; no immediate financial impact.
- Value
- ₹0.68 Cr
Span Divergent Q2 FY27 Results: Net Loss of ₹0.8 Cr, Loss Widens
Span Divergent Ltd reported revenue from operations of ₹5.4 Cr (-28.9% YoY) and a net loss of ₹0.8 Cr for Q2 FY27.
- Key figure
- Net loss ₹0.8 Cr
Other other announcement announcements
All →Fundviser Capital (India) Other Announcement
Fundviser Capital's quarterly Regulation 32 statement confirms no deviation in use of preferential warrant proceeds. Funds utilised total ₹38.10 Crore against ₹79.44 Crore raised.
Austere Systems Other Announcement
Austere Systems appointed EquiBridgeX Advisors as its Investor Relations and Public Relations agency effective November 5, 2026. The filing states no fees or financial terms.
Kiri Industries Other Announcement
Kiri Industries filed the Crisil monitoring agency report for the quarter ended September 30, 2026. The report covers utilisation of preferential warrant issue proceeds with no deviations.
Sahajanand Medical Technologies Other Announcement
Sahajanand Medical Technologies appointed Amit Jaste & Associates as Secretarial Auditor for 60 months, effective 5 November 2026. Approved at the same-day board meeting.
- Execution
- 60 months
Dr. Agarwals Health Care Other Announcement
Dr. Agarwal's Health Care submitted ICRA's monitoring agency report for the quarter ended September 30, 2026. ICRA reports no material deviation in IPO proceeds utilisation.
Cello World Other Announcement
Cello World's QIP monitoring report shows no fund deviation for the quarter ended September 2026. Object 1 is delayed, with Rs.1.51 crore unutilised.